Press Releases

Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case Mont-Saint-Guibert, Belgium – November 18, 2026, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for

Continue Reading...

Geekvape launches VPU 2.0 atomisation platform in Dubai

DUBAI, United Arab Emirates, Nov. 17, 2026 (GLOBE NEWSWIRE) — Geekvape unveiled VPU 2.0, its next-generation atomisation technology platform, on 10 November 2026. Built around upgrades to wicking materials, mesh coils and device coordination, the platform combines material science, precision heating and intelligent control to improve e-liquid delivery, heating uniformity

Continue Reading...

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

– REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinically meaningful reduction in risk of death by 41% with median overall survival of 24.0 months versus 14.7 months for best available treatment, and a hazard ratio of 0.59 (p=0.035) – – Company plans to meet with

Continue Reading...